Early warning test for sepsis in the emergency department
Part of Infections clinical trials.
This study is testing whether a special blood test can help predict sepsis earlier in people who come to the emergency department. It might help get faster treatment and better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need a score of 2 or more on a test called MSS (a measure of how sick you are).
- You must be willing to give written permission to join the study.
- You cannot have cancer, HIV, or any life-limiting illness.
- You cannot be pregnant or breastfeeding.
- You must not be in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two new blood tests to see if they can help doctors find sepsis earlier in the emergency department. Sepsis is a serious condition where the body overreacts to an infection, and finding it quickly could lead to faster treatment and better outcomes.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This study uses a blood sample to look at a type of white blood cell that may help doctors identify how serious an infection is early on. By joining, you may help improve how sepsis is detected and treated.
This trial tests whether a quick genetic test can help doctors choose the right treatment for patients with a suspected severe infection (sepsis) more quickly. The goal is to improve recovery by personalizing care based on your body's response.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.